Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 170   

Articles published

NVS 80.63 -0.75 (-0.92%)
price chart
1832 Asset Management LP Has Decreased Its Novartis A G (NVS) Position; MKS ...
Novartis A G now has $210.15 billion valuation. The stock declined 0.90% or $0.73 reaching $80.65 per share. About 1.27M shares traded.
Cambridge Trust Company Lowered By $11.80 Million Its Novartis Ag Sponsored ...
Cambridge Trust Company decreased Novartis Ag Sponsored Adr (NVS) stake by 70.76% reported in 2016Q4 SEC filing. Cambridge Trust Company sold 163,889 shares as Novartis Ag Sponsored Adr (NVS)'s stock rose 4.17%. The Cambridge Trust ...
Campbell Soup (CPB) Covered By PiperJaffray with $59 Target; Novartis AG (NVS ...
The SI to Novartis AG's float is 0.2%. The stock increased 0.42% or $0.34 during the last trading session, reaching $81.4. About shares traded.
Northeast Investment Management Cut Its Novartis Ag Spons Adr (NVS) Stake ...
Northeast Investment Management decreased Novartis Ag Spons Adr (NVS) stake by 24.87% reported in 2016Q4 SEC filing.
Boulegeris Investments Lowered Novartis A G (NVS) Holding; 4 Analysts Bullish ...
Novartis A G now has $216.08B valuation. The stock rose 0.02% or $0.02 reaching $81.31. About 356,137 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since May 23, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.
Traders Alert BRF SA (ADR) (NYSE:BRFS), Novartis AG (ADR) (NYSE:NVS)
Shares of Novartis AG (ADR) (NYSE:NVS) inclined 1.08% to $81.09. Stock exchanged hands with the total volume of 5.88 Million shares, as contrast to its average volume of 2.57 Million shares.
Guggenheim Capital Has Decreased Novartis A G (NVS) Holding, Terra Tech (TRTC ...
Novartis A G now has $212.86B valuation. The stock declined 0.06% or $0.05 reaching $81.35 per share. About 578,275 shares traded.
Novartis AG (ADR) (NYSE:NVS) & Banco Santander Brasil SA (ADR) (NYSE:BSBR ...
Novartis AG (ADR) (NYSE:NVS) have shown a low EPS growth of -5.80% in the last 5 years and has earnings growth of -16.80% yoy.
Novartis AG (ADR) (NYSE:NVS)'s push to win approval for Zykadia
Novartis AG (NYSE:NVS)'s push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
John G Ullman & Associates Upped Novartis Ag (NVS) Holding By $3.69 Million ...
Novartis Ag now has $213.52B valuation. The stock increased 1.08% or $0.87 during the last trading session, reaching $81.29. About 4,000 shares traded.